The University of Kansas Hospital (UKHA) this week sued the federal government for authorizing Johnson & Johnson (J&J) to audit [...] …
Year: 2025

SPONSORED CONTENT

TIP: Master manufacturer refund challenges with actionable steps.
Managing manufacturer refunds in the 340B Drug Pricing Program
News Alert
Dark-Money 340B Attacks, Rebate Model Among Key Concerns at 340B Coalition Winter Conference
Concerns over a highly charged and misleading dark-money campaign targeting state contract pharmacy access bills and the legal fight surrounding [...] …
A federal judge yesterday rejected Swiss pharmaceutical company Novartis’ bid to block Missouri’s law prohibiting drugmaker 340B contract pharmacy restrictions [...] …
California lawmakers have introduced a 340B contract pharmacy access bill; Michigan legislators introduced a contract pharmacy bill that also includes [...] …
U.S. House lawmakers are expected to vote as early as Tuesday on a budget resolution that calls for reducing health [...] …
SPONSORED CONTENT
The healthcare landscape is evolving rapidly, and with it, the need for stronger, smarter partnerships has never been greater. Covered entities are navigating a time of uncertainty, where operational challenges, regulatory scrutiny, and resource constraints are putting unprecedented pressure on healthcare organizations. That’s why
…
Sagebrush Health, a Nevada-based STD clinic, has voluntarily dismissed its 340B lawsuit against the federal government—a move the clinic says [...] …
UK-based drugmaker GlaxoSmithKline (GSK) will reinstate its contract pharmacy restrictions in Kansas next month, making it the fourth drug manufacturer [...] …
The North Dakota House and the South Dakota Senate have each overwhelmingly voted to pass bills that would prohibit drugmakers [...] …